AI assistant
Sending…
XERO LIMITED — Director's Dealing 2016
Apr 5, 2016
66106_rns_2016-04-05_9ff6e2e3-57f8-4fd3-b7a1-3fe1c1818b59.pdf
Director's Dealing
Open in viewerOpens in your device viewer

Ongoing Disclosure Notice
Disclosure of Directors and Senior Managers Relevant Interests
Sections 297(2) and 298(2), Financial Markets Conduct Act 2013
| To NZX Limited; and | |
|---|---|
| Name of listed issuer: | Хe |
| Date this disclosure made: | |
| Date of last disclosure: | 14 |
Director or senior manager giving disclosure
| Full name(s): | |
|---|---|
| Name of listed issuer: | Xe |
| Name of related body corporate (if applicable): | N c |
| Position held in listed issuer: | Cł |
| Xero Limited (XRO) | |
|---|---|
| 2016 April 2016 | |
| 14 August 2015 |
| Angus Norton | |
|---|---|
| Xero Limited (XRO) | |
| Not applicable | |
| Chief Product Officer |
Summary of acquisition or disposal of relevant interest (excluding specified derivatives)
Class of affected quoted financial products:
Nature of the affected relevant interest(s):
Number held in class before acquisition or disposal:
Number held in class after acquisition or disposal:
Current registered holder(s):
For that relevant interest-
Registered holder(s) once transfers are registered:
| (b) Unlisted conditional Stock Units or RSUs) |
(a) Ordinary shares in Xero Limited (Ordinary Shares); contractual right to be issued Ordinary Shares (Restricted |
|
|---|---|---|
| Plan) | (a) Legal ownership of Stock Unit Plan (NZ) (NZ |
Ordinary Shares; (b) Holder of RSUs, subject to the terms of the Xero Limited Restricted |
| (a) 12,000; (b) 53,315 | ||
| (a) 37,772; (b) 27,543 | ||
| Norton | (a) Angus Norton; (b) Angus | |
| Norton | (a) Angus Norton; (b) Angus |
Summary of acquisition or disposal of specified derivatives relevant interest (if applicable)
| Type of affected derivative: | Not applicab |
|---|---|
| Class of underlying financial products: | Not applicab |
| Details of affected derivative- | |
| The notional value of the derivative (if any) or the notional amount of underlying financial products (if any): |
Not applicab |
| A statement as to whether the derivative is cash settled or physically settled: | Not applicab |
| Maturity date of the derivative (if any): | Not applicab |
| Expiry date of the derivative (if any): | Not applicab |
| The price specified in the terms of the derivative (if any): | Not applicab |
| Any other details needed to understand how the amount of the consideration payable under the derivative or the value of the derivative is affected by the value of the underlying financial products: |
Not applicab |
| For that derivative.- | |
| Parties to the derivative: | Not applicab |
| If the director or senior manager is not a party to the derivative, the nature of the relevant interest in the derivative: |
Not applicab |
| Details of transactions giving rise to acquisition or disposal | ||
|---|---|---|
| ---------------------------------------------------------------- | -- | -- |
| Total number of transactions to which notice relates: | |
|---|---|
| Details of transactions requiring disclosure- | |
| Date of transaction: | 31 March 2016 |
| Nature of transaction: | Issue of Ordinary Shares upon vesting of RSUs allocated under the NZ Plan |
| Not applicable | |
|---|---|
| Not applicable | |
| Not applicable | |
| Not applicable | |
| Not applicable | |
|---|---|
| Not applicable | |
| Not applicable | |
le
| Not applicable | |
|---|---|
| Not applicable |
| Name of any other party or parties to the transaction (if known): | Not applicable |
|---|---|
| The consideration, expressed in New Zealand dollars, paid or received for the acquisition or disposal. If the consideration was not in cash and cannot be readily by converted into a cash value, describe the consideration: |
25,772 Ordinary Shares were issued upon vesting of 25,772 RSUs granted under the NZ Plan as part of the remuneration package of Angus Norton (in his role as Chief Product Officer). No cash consideration was required to be paid for the RSUs to vest |
| Number of financial products to which the transaction related: | $\mathbf{1}$ |
| If the issuer has a financial products trading policy that prohibits directors or senior managers from trading during any period without written clearance (a closed period) include the following details- |
|
| Whether relevant interests were acquired or disposed of during a closed period: | Yes |
| Whether prior written clearance was provided to allow the acquisition or disposal to proceed during the closed period: |
Not applicable. Issue of Ordinary Shares upon vesting of RSUs in accordance with the NZ Plan |
| Date of the prior written clearance (if any): | Not applicable |
| Class of quoted financial products: Nature of relevant interest: |
Not applicable Not applicable |
| For that relevant interest.- | |
| Number held in class: | Not applicable |
| Current registered holder(s): | Not applicable |
| For a derivative relevant interest,- | |
| Type of derivative: | Not applicable |
| Details of derivative,- | |
| The notional value of the derivative (if any) or the notional amount of underlying financial products (if any): |
Not applicable |
| A statement as to whether the derivative is cash settled or physically settled: | Not applicable |
| Maturity date of the derivative (if any): | Not applicable |
| Expiry date of the derivative (if any): | Not applicable |
| The price's specified terms (if any): | Not applicable |
| Any other details needed to understand how the amount of the consideration payable under the derivative or the value of the derivative is affected by the value of the underlying financial products: |
Not applicable |
| For that derivative relevant interest,- | |
| Parties to the derivative: | Not applicable |
| If the director or senior manager is not a party to the derivative, the nature of the relevant interest in the derivative: |
Not applicable |
| Certification |
| l certify that, to the best of my knowledge and belief, the information contained in this disclosure is l correct and that I am duly authorised to make this disclosure by all persons for whom it is made. |
|
|---|---|
| Signature of director or officer: |
---Docusigned by:
Angus Norton
---254C12BBFA4B4A2...
$4/4/2016$ | 22:48:17
PT
Date of signature:
More from XERO LIMITED
Director's Dealing
2026
Jun 2
Share Issue/Capital Change
2026
Jun 2
Share Issue/Capital Change
2026
May 27
Major Shareholding Notification
2026
May 25
Governance Information
2026
May 13
Earnings Release
2026
May 13
Investor Presentation
2026
May 13
Environmental & Social Information
2026
May 13
Annual Report
2026
May 13
Share Issue/Capital Change
2026
Apr 30